BRK-B vs HNNA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
HNNA exhibits a strong deterministic health profile with a Piotroski F-Score of 8/9 and a negligible debt-to-equity ratio of 0.01, indicating a pristine balance sheet. While the stock is significantly undervalued relative to its Graham Number ($18.01) and trades at a low P/E of 8.61, this value is offset by alarming growth trends, with revenue and earnings declining by 14.3% and 33.3% respectively. The company functions as a high-yield value play with a sustainable 6.06% dividend, but lacks a catalyst for price appreciation given the bearish technical trend and negative growth trajectory.
Compare Another Pair
Related Comparisons
BRK-B vs HNNA: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Hennessy Advisors, Inc. (HNNA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.